Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $277,602 - $320,661
-4,345 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $63,053 - $69,517
990 Added 29.51%
4,345 $302,000
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $196,401 - $227,938
3,355 New
3,355 $220,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stevard, LLC Portfolio

Follow Stevard, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevard, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stevard, LLC with notifications on news.